Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.21.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Feb. 28, 2021
Nov. 30, 2020
CURRENT ASSETS    
Cash $ 1,975 $ 3,175
Restricted cash 2,154 6,389
Accounts receivable, net 321 834
Inventory, net 7,585 4,817
Net investment in sales-type lease, current 39  
Prepaid expenses and other current assets 845 1,391
Total current assets 12,919 16,606
Patent rights, net 795 811
Deposits for equipment 619 619
Right-of-use asset, net 1,268 1,200
Net investment in sales-type lease, non-current 67  
Property and equipment, net 1,044 1,220
Goodwill 651 651
Restricted cash 92 92
Other assets 70 17
TOTAL ASSETS 17,525 21,216
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 5,989 6,629
Operating lease liabilities, current 212 257
Deferred revenue 1,328 4,902
Notes payable, current   76
Total current liabilities 7,529 11,864
Notes payable, non-current   115
Operating lease liabilities, noncurrent 952 828
Total liabilities 8,481 12,807
COMMITMENTS AND CONTINGENCIES (NOTE 21)  
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued; Series A Preferred Stock, 1,500 shares designated, 1,391 and 0 shares issued and outstanding, respectively  
Common stock, $0.001 par value, 300,000,000 shares authorized, 149,201,088 and 148,520,227 shares issued and outstanding, respectively 149 148
Additional paid-in capital 59,296 58,448
Shares to be issued  
Treasury stock, at cost, 0 and 3,699,999 shares, respectively  
Accumulated deficit (50,487) (50,215)
Accumulated other comprehensive income (loss) 86 28
Total Stockholders' Equity (Deficit) 9,044 8,409
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 17,525 $ 21,216